OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $952,000 | -55.7% | 233,793 | -53.7% | 0.02% | -46.8% |
| Q1 2022 | $2,149,000 | -89.3% | 504,505 | -76.5% | 0.05% | -86.8% |
| Q4 2021 | $20,128,000 | -66.0% | 2,150,404 | 0.0% | 0.36% | -56.8% |
| Q3 2021 | $59,265,000 | -1.5% | 2,150,404 | 0.0% | 0.82% | -15.0% |
| Q2 2021 | $60,168,000 | -15.7% | 2,150,404 | 0.0% | 0.97% | -10.2% |
| Q1 2021 | $71,350,000 | -31.0% | 2,150,404 | 0.0% | 1.08% | -25.5% |
| Q4 2020 | $103,391,000 | – | 2,150,404 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |